Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · IEX Real-Time Price · USD
4.180
-0.090 (-2.11%)
At close: Mar 28, 2024, 4:00 PM
4.260
+0.080 (1.91%)
After-hours: Mar 28, 2024, 6:16 PM EDT

Century Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Net Income
-136.67-130.93-95.82-53.58
Depreciation & Amortization
11.8510.074.581.75
Share-Based Compensation
14.6210.674.660.88
Other Operating Activities
21.86124.24-2.429.68
Operating Cash Flow
-88.3514.05-89-41.27
Capital Expenditures
-13.74-30.6-44.97-9.83
Acquisitions
000-4.72
Change in Investments
74.8717.48-253.37-8.21
Investing Cash Flow
61.13-13.13-298.34-22.76
Share Issuance / Repurchase
0.5227.16258.1538.1
Debt Issued / Paid
-10.24009.73
Other Financing Activities
--159.63-0.14
Financing Cash Flow
-9.7327.16417.7747.69
Net Cash Flow
-36.9428.0830.43-16.34
Free Cash Flow
-102.08-16.55-133.97-51.09
Free Cash Flow Margin
-4567.52%-318.37%--
Free Cash Flow Per Share
-1.72-0.29-4.14-6.83
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).